Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/16/19
End: 05/03/21
Due: 05/03/22
Phase: N/A
Priority: Normal
Start: 04/21/25
End: 10/27/25
Due: 10/27/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Single Ascending Dose Study of ALA-1000 | NCT04122755 | Alar Pharmaceuticals Inc. | user2@example.com | None | 2019-09-16 | 2021-05-03 | 2022-05-03 | - | - | 2025-07-14 |
| Multiple Ascending Dose Phase 1 Study of ALA-3000 | NCT06965569 | Alar Pharmaceuticals Inc. | user2@example.com | None | 2025-04-21 | 2025-10-27 | 2026-10-27 | - | - | 2025-07-14 |